Archives

Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-15
    E.g., 2018-10-15

Archive Search

8 results
12:00 AM, Sep 22, 2014  |  BC Week In Review | Clinical News  |  Clinical Status

Twirla: Phase III started

pregnancy. Twirla will be applied every week for 3 consecutive weeks in a 4-week cycle. Agile Therapeutics Inc
12:00 AM, Oct 11, 2010  |  BC Week In Review | Clinical News  |  Clinical Status

Seven-day contraceptive patch: Completed Phase III enrollment

7-day patch once weekly for 3 weeks followed by 1 week patch-free for 12 months. Agile Therapeutics Inc
12:00 AM, Aug 16, 2010  |  BC Week In Review | Clinical News  |  Clinical Status

Seven-day contraceptive patch: Phase III started

Agile Therapeutics began an open-label, U.S Phase III trial to compare AG200-15 vs. low dose oral contraceptives …
be applied once weekly for 3 weeks followed by 1 week patch-free for 12 months. Agile Therapeutics Inc
12:00 AM, Nov 24, 2008  |  BC Week In Review | Clinical News  |  Clinical Status

Seven-day contraceptive patch: Phase III start

1,000 women. Agile Therapeutics Inc
12:00 AM, Jul 22, 2002  |  BC Week In Review | Clinical News  |  Clinical Status

Seven-day contraceptive patch: Agile began a Phase II trial in the U.S. and Australia of its 7-day transdermal combination contraceptive patch in 162 subjects

Agile Therapeutics Inc. , West Conshohocken, Penn.   Product: Seven-day contraceptive patch   Business: Reproductive   Therapeutic category …
12:00 AM, Aug 13, 2001  |  BC Week In Review | Clinical News  |  Clinical Status

Seven-day contraceptive patch: Began Phase I trials

Agile Therapeutics Inc. , West Conshohocken, Penn.   Product: Seven-day contraceptive patch   Business: Reproductive   Therapeutic category …
12:00 AM, May 21, 2001  |  BC Week In Review | Clinical News  |  Clinical Status

Seven-day contraceptive patch: Began Phase II trials

Agile Therapeutics Inc., West Conshohocken, Penn.   Product: Seven-day contraceptive patch   Business: Reproductive   Therapeutic category: Hormone …
12:00 AM, Jun 28, 1999  |  BC Week In Review | Clinical News  |  Clinical Status

Seven-day contraceptive patch: Completed Phase II/III study

Levotech Inc., West Conshohocken, Penn.   Product: Seven-day contraceptive patch   Business: Reproductive   Therapeutic category …
  Description: Patch containing transdermal formulations of progestin and estrogen   Indication: Contraception   Status: Levotech